Search
for
Sort by
Research 151–180 of 777
- Immunological control of skin development: from homeostasis to developmental pathologies
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Molecular pathology of skin adnexal tumours
- New Treatments for Hair Loss
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- The role of lymphocytes in the development and treatment of alopecia areata
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- TNC+ fibroblasts involve in skin inflammation via neuro-immune and interacting with T cells
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases?
- Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib
- JAK inhibitors in dermatology: The promise of a new drug class
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- JAK Inhibitors for Treatment of Alopecia Areata
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Role of bulge epidermal stem cells and TSLP signaling in psoriasis
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Increase in IL-15 levels in patients with alopecia areata
- Mechanisms of Puerariae Lobatae Radix in regulating sebaceous gland secretion: insights from network pharmacology and experimental validation